Wrinkle Injections & Botulinum Toxin

Bentley C. Botulinum neurotoxin A in ophthalmology. Ophthalmic Physiol Opt. 1996 Mar;16 Suppl 1:S9-14. Department of Neuro-ophthalmology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.

Matarasso SL. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides. Dermatol Surg. 2003 Jan;29(1):7-13; discussion 13. University of California School of Medicine, San Francisco, California 94102, USA.

Riemann R, Pfennigsdorf S, Riemann E, Naumann M. Ophthalmology. Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: a case report. 1999 Dec;106(12):2322-4. Department of Otorhinolaryngology/Head and Neck Surgery, University of Wurzburg, Germany.

O'Day J. Use of botulinum toxin in neuro-ophthalmology. Curr Opin Ophthalmol. 2001 Dec;12(6):419-22. Department of Ophthalmology, University of Melbourne, Australia.

Frampton JE, Easthope SE. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines. Am J Clin Dermatol. 2003;4(10):709-25. Adis International Inc, Yardley, Pennsylvania 19047, USA.

Tsui JK. Botulinum toxin as a therapeutic agent. Pharmacol Ther. 1996;72(1):13-24.Department of Medicine, University of British Columbia, Vancouver, Canada.

Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):249-59. Departments of Dermatology and Ophthalmology, Cleveland Clinic Foundation, USA.

Latimer PR, Hodgkins PR, Vakalis AN, Butler RE, Evans AR, Zaki GA. Necrotising fasciitis as a complication of botulinum toxin injection. Eye. 1998;12 (Pt 1):51-3. Department of Ophthalmology, Queen Alexandra Hospital, Portsmouth, UK.

Trasciatti S, Podesta A, Bonaretti S, Mazzoncini V, Rosini S. In vitro effects of different formulations of bovine collagen on cultured human skin. Biomaterials. 1998 May;19(10):897-903. Abiogen Pharma Research Centre, Migliarino Pisano, Pisa, Italy.

Hoppe U, Bergemann J, Diembeck W, Ennen J, Gohla S, Harris I, Jacob J, Kielholz J, Mei W, Pollet D, Schachtschabel D, Sauermann G, Schreiner V, Stab F, Gomes SA, Thomson M, Ali M, Alnaqeeb M, Khater SH. Collagen toxicity in rabbits. Toxicol Lett. 1991 Apr;56(1-2):229-35. Department of Biochemistry, Faculty of Science, Kuwait University, Safat.

Shiffman MA, Kaminski MV. Fat transfer to the face: technique and new concepts. Facial Plast Surg Clin North Am. 2001 May;9(2):229-37, viii. Finch University of Health Sciences Medical School, Chicago, IL, USA.

Boss WK Jr, Usal H, Fodor PB, Chernoff G. Autologous cultured fibroblasts: a protein repair system. Ann Plast Surg. 2000 May;44(5):536-42. University of Medicine and Dentistry of New Jersey, Department of Plastic Surgery, Hackensack University Medical Center, USA.

Watson D, Keller GS, Lacombe V, Fodor PB, Rawnsley J, Lask GP. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. A pilot study. Arch Facial Plast Surg. 1999 Jul-Sep;1(3):165-70. Division of Head and Neck Surgery, University of California, Los Angeles, USA.

Hotta T. Dermal fillers. The next generation. Plast Surg Nurs. 2004 Jan-Mar;24(1):14-9.

Price RD, Das-Gupta V, Harris PA, Leigh IM, Navsaria HA. The role of allogenic fibroblasts in an acute wound healing model. Plast Reconstr Surg. 2004 May;113(6):1719-29. Department of Plastic Surgery, Wythenshawe Hospital, Queen Mary, University of London, Barts & London Medical School, 2 Newark Street, London, United Kingdom.

Duranti F, Salti G, Bovani B, Calandra M, Rosati ML. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg. 1998 Dec;24(12):1317-25. Angio-Dermo-Surgery Center, University of Perugia School of Medicine, Italy.

Honig JF, Brink U, Korabiowska M. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Craniofac Surg. 2003 Mar;14(2):197-200. Department of Craniofacial and Plastic Surgery and Pathology, University Hospital and Medical School of Goettingen, Germany.

Lupton JR, Alster TS. Dermatol Surg. 2000 Feb;26(2):135-7. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Washington Institute of Dermatologic Laser Surgery, Washington, D.C. 20037, USA.

Lowe NJ, Maxwell CA, Lowe P, Duick MG, Shah K. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001 Dec;45(6):930-3. Cranley Clinic for Dermatology, London, England.

Manna F, Dentini M, Desideri P, De Pita O, Mortilla E, Maras B. Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (hylaform from rooster combs and restylane from streptococcus) used for soft tissue augmentation. J Eur Acad Dermatol Venereol. 1999 Nov;13(3):183-92. Department of Chemical and Technological Studies of Biologically Active Substances, University La Sapienza, Rome, Italy.

Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2003 Sep-Oct;27(5):354-66; discussion 367. Epub 2003 Dec 4. Division of Plastic Surgery, University of California, San Diego, CA, USA.

Mang WL, Sawatzki K. Complications after implantation of PMMA for soft tissue augmentation. (1998). Zeitschrift fur Haut-Krankheiten, 73(1), 42-44.